View Amendment Current Amendment: 42A to Bill 150

Senator CROMER proposed the following amendment (VR\150C003.CC.VR22):

Amend the bill, as and if amended, SECTION 3, page 9, by striking 44-53-2020(B)(6) and inserting:

/ (6)five percent for research conducted by the University of South Carolina College of Pharmacy and School of Medicine, the Medical University of South Carolina, or an established pharmaceutical company located in this State that is approved by the department to be used in connection with medical cannabis research and development, including use for:

(a) clinical trials regarding the effectiveness of cannabis products at treating symptoms and conditions that are not debilitating medical conditions pursuant to this article;

(b) data collection from qualifying patients who voluntarily provide information related to dosage, efficacy, and side effects;

(c) clinical trials, observational studies, or both on the dosage, efficacy, and side effects of medical cannabis; and

(d) the publication of dosage recommendations based upon medical conditions or symptoms, modes of administration, and cannabinoid profiles. /